Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29658856

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 May 31
First author
Gandhi L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2018 Jun;8(6):OF7. doi: 10.1158/2159-8290.CD-NB2018-051.
    note
    Source null
    related pmid
    29666060
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2018 Jul;15(7):402-403. doi: 10.1038/s41571-018-0031-1.
    note
    Source null
    related pmid
    29725041
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 May 31;378(22):2135-2137. doi: 10.1056/NEJMe1804364.
    note
    Source null
    related pmid
    29847766
    relationship
    Comment in
  4. citation
    Immunity. 2018 Jun 19;48(6):1077-1080. doi: 10.1016/j.immuni.2018.06.003.
    note
    Source null
    related pmid
    29924973
    relationship
    Comment in
  5. citation
    Nat Rev Clin Oncol. 2018 Oct;15(10):593-594. doi: 10.1038/s41571-018-0070-7.
    note
    Source null
    related pmid
    29993034
    relationship
    Comment in
  6. citation
    N Engl J Med. 2018 Sep 13;379(11):e18. doi: 10.1056/NEJMc1808567.
    note
    Source null
    related pmid
    30211498
    relationship
    Comment in
  7. citation
    N Engl J Med. 2018 Sep 13;379(11):e18. doi: 10.1056/NEJMc1808567.
    note
    Source null
    related pmid
    30211499
    relationship
    Comment in
  8. citation
    N Engl J Med. 2018 Sep 13;379(11):e18. doi: 10.1056/NEJMc1808567.
    note
    Source null
    related pmid
    30211501
    relationship
    Comment in
  9. citation
    Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S202-S205. doi: 10.21037/tlcr.2018.07.03.
    note
    Source null
    related pmid
    30393601
    relationship
    Comment in
  10. citation
    Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S208-S210. doi: 10.21037/tlcr.2018.07.15.
    note
    Source null
    related pmid
    30393603
    relationship
    Comment in
  11. citation
    J Thorac Dis. 2018 Sep;10(9):5184-5185. doi: 10.21037/jtd.2018.09.21.
    note
    Source null
    related pmid
    30416763
    relationship
    Comment in
  12. citation
    J Thorac Dis. 2018 Sep;10(9):5186-5189. doi: 10.21037/jtd.2018.09.05.
    note
    Source null
    related pmid
    30416764
    relationship
    Comment in

Authors and identifiers

  1. name
    Gandhi L
    type
    Author
  2. name
    Rodríguez-Abreu D
    type
    Author
  3. name
    Gadgeel S
    type
    Author
  4. name
    Esteban E
    type
    Author
  5. name
    Felip E
    type
    Author
  6. name
    De Angelis F
    type
    Author
  7. name
    Domine M
    type
    Author
  8. name
    Clingan P
    type
    Author
  9. name
    Hochmair MJ
    type
    Author
  10. name
    Powell SF
    type
    Author
  11. name
    Cheng SY
    type
    Author
  12. name
    Bischoff HG
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gandhi L
    type
    Author
  2. name
    Rodríguez-Abreu D
    type
    Author
  3. name
    Gadgeel S
    type
    Author
  4. name
    Esteban E
    type
    Author
  5. name
    Felip E
    type
    Author
  6. name
    De Angelis F
    type
    Author
  7. name
    Domine M
    type
    Author
  8. name
    Clingan P
    type
    Author
  9. name
    Hochmair MJ
    type
    Author
  10. name
    Powell SF
    type
    Author
  11. name
    Cheng SY
    type
    Author
  12. name
    Bischoff HG
    type
    Author
bibliography ids
  1. nci-bib-e7a027653f3da0b995699990
book metadata
content sha256
060784438765a7fb85ef605d4bd5696ff9e2d8d50ebf7918e4250bb6f98754e9
document type
citation
dois
  1. 10.1056/NEJMoa1801005
electronic publication date
display
2018 Apr 16
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29658856
immutable id
pubmed:29658856@060784438765a7fb85ef605d4bd5696ff9e2d8d50ebf7918e4250bb6f98754e9
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
22
name
The New England journal of medicine
nlm unique id
0255562
pages
2078-2092
volume
378
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2018 Jun;8(6):OF7. doi: 10.1158/2159-8290.CD-NB2018-051.
    note
    Source null
    related pmid
    29666060
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2018 Jul;15(7):402-403. doi: 10.1038/s41571-018-0031-1.
    note
    Source null
    related pmid
    29725041
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 May 31;378(22):2135-2137. doi: 10.1056/NEJMe1804364.
    note
    Source null
    related pmid
    29847766
    relationship
    Comment in
  4. citation
    Immunity. 2018 Jun 19;48(6):1077-1080. doi: 10.1016/j.immuni.2018.06.003.
    note
    Source null
    related pmid
    29924973
    relationship
    Comment in
  5. citation
    Nat Rev Clin Oncol. 2018 Oct;15(10):593-594. doi: 10.1038/s41571-018-0070-7.
    note
    Source null
    related pmid
    29993034
    relationship
    Comment in
  6. citation
    N Engl J Med. 2018 Sep 13;379(11):e18. doi: 10.1056/NEJMc1808567.
    note
    Source null
    related pmid
    30211498
    relationship
    Comment in
  7. citation
    N Engl J Med. 2018 Sep 13;379(11):e18. doi: 10.1056/NEJMc1808567.
    note
    Source null
    related pmid
    30211499
    relationship
    Comment in
  8. citation
    N Engl J Med. 2018 Sep 13;379(11):e18. doi: 10.1056/NEJMc1808567.
    note
    Source null
    related pmid
    30211501
    relationship
    Comment in
  9. citation
    Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S202-S205. doi: 10.21037/tlcr.2018.07.03.
    note
    Source null
    related pmid
    30393601
    relationship
    Comment in
  10. citation
    Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S208-S210. doi: 10.21037/tlcr.2018.07.15.
    note
    Source null
    related pmid
    30393603
    relationship
    Comment in
  11. citation
    J Thorac Dis. 2018 Sep;10(9):5184-5185. doi: 10.21037/jtd.2018.09.21.
    note
    Source null
    related pmid
    30416763
    relationship
    Comment in
  12. citation
    J Thorac Dis. 2018 Sep;10(9):5186-5189. doi: 10.21037/jtd.2018.09.05.
    note
    Source null
    related pmid
    30416764
    relationship
    Comment in
outcomes validated
false
pmid
29658856
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
da64064b90e59c5ea1d609b312cc6bdf423419ebf855f9832fd661db68875616
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 May 31
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29658856/
title
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

Preserved source evidence · Not medical advice